Effects of topiramate in patients with epilepsy and intellectual impairment;Effekte von topiramat bei patienten mit epilepsie und intellektueller beeinträchtigung

Nervenarzt

Volumn 73, Issue 6, 2002, Pages 525-532

  Huber, B ^a  

^a EPILEPSY CENTER BETHEL   (Germany)

Author keywords

Epilepsy; Mental retardation; Neuropsychiatric complications; Open prospective study; Topiramate

Indexed keywords

LAMOTRIGINE; TOPIRAMATE; VALPROIC ACID;

ADD ON THERAPY; ARTICLE; BRAIN INJURY; COMPARATIVE STUDY; CONFUSION; DISEASE SEVERITY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG EFFICACY; EPILEPSY; EVALUATION; HUMAN; INTELLECTUAL IMPAIRMENT; MENTAL DISEASE; OPEN STUDY; PROSPECTIVE STUDY; SEIZURE; THOUGHT DISORDER; TREATMENT OUTCOME;

ADULT; ANTICONVULSANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; ELECTROENCEPHALOGRAPHY; EPILEPSY; FEMALE; FOLLOW-UP STUDIES; FRUCTOSE; HUMANS; MALE; MENTAL RETARDATION; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; TREATMENT OUTCOME;

EID: 0036937871     PISSN: 00282804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00115-002-1294-3     Document Type: Article

References (19)

1. Ben-Menachem E, Henriksen O, Dam M et al. (1996) Double-blind, placebo-controlled trial of topiramate as add-on therapy in patients with refractory partial seizures. Epilepsia 37 (6):539-543
2. Biton V, Edwards KR, Montouris GD, Sackellares JC, Harden CL, Kamin M (2001) Topiramate titration and tolerability. Ann Pharmacother 35 (2):173-179
3. Branford D, Bhaumik S, Duncan F (1998) Epilepsy in adults with learning disabilities. Seizure 7 (6):473-477
4. Coppola G, Pascotto A (1997) Lamotrigine as add-on drug in children and adolescents with refractory epilepsy and mental delay: an open trial. Brain Dev 19 (6):398-402
5. Crawford P (1998) An audit of topiramate use in a general neurology clinic. Seizure 7 (3):207-211
6. Faught E, Wilder BJ, Ramsay RE et al. (1996) Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 200-, 400-, and 600-mg daily dosages. Topiramate YD Study Group. Neurology 46 (6):1684-1690
7. Forsgren L, Edvinsson SO, Blomquist HK, Heijbel J, Sidenvall R (1990) Epilepsy in a population of mentally retarded children and adults. Epilepsy Res 6 (3):234-248
8. Gidal BE, Walker JK, Lott RS, Shaw R, Speth J, Marty KJ, Rutecki P (2000) Efficacy of lamotrigine in institutionalized, developmentally disabled patients with epilepsy: a retrospective evaluation. Seizure 9 (2):131-136
9. Huber B, Gadke-Hopf J, Tomka-Hoffmeister M (1998) Efficacy of Gabapentin in Multihandicapped Therapy-Resistant Epileptic Patients. Poster at the 3rd European Congress of Epileptology 24.-28.05.1998 Warshaw
10. Huber B, May T, Seidel M (1998) Lamotrigine in Multihandicapped Therapy-Resistant Epileptic Patients. Clin Drug Invest 16 (4):263-277
11. Huppertz HJ, Quiske A, Schulze-Bonhage A (2001) Kognitive Beeinträchtigungen unter Add-on-Therapie mit Topiramat. Nervenarzt 72 (4):275-280
12. Linden M, Baier D, Beitinger H et al. (1994) Leitlinien zur Durchführung von Anwendungsbeobachtungen in der Psychopharmakatherapie. Nervenarzt 6S:638-644
13. Martin R, Kuzniecky R, Ho S, Hetherington H, Pan J, Sindair K, Giliam F, Faught E (1999) Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults. Neurology 52 (2):321-327
14. Meador KJ (2001) Effects of topiramate on cognition. J Neurol Neurosurg Psychiatry 71 (1):134-135
15. Privitera M, Fincham R, Penry J, Reife R, Kramer L, Pledger G, Karim R (1996) Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 600-, 800-, and 1,00-mg daily dosages. Topiramate YE Study Group. Neurology 46 (6):1678-1683
16. Sachdeo RC, Glauser TA, Ritter F, Reife R, Lim P, Pledger G (1999) A double-blind, randomized trial of topiramate in Lennox-Gastaut syndrome. Topiramate YL Study Group. Neurology 52(9):1882-1887
17. Sharief M, Viteri C, Ben-Menachem E, Weber M, Reife R, Pledger G, Karim R (1996) Double-blind, placebo-controlled study of topiramate in patients with refractory partial epilepsy. Epilepsy Res 25 (3):217-224
18. Shorvon SD (1996) Safety of topiramate: Adverse events and relationships to dosing. Epilepsia 37:S18-S22
19. Task Force der Internationalen Liga gegen Epilepsie (ILAE) zur Klassifikation und Terminologie (2001) Vorschlag für ein diagnostisches Schema für Menschen mit epileptischen Anfällen und Epilepsien. Z Epileptol 14:59-68